- Home
- NPCE vs OXSQ Comparison
NPCE vs OXSQ Comparison
Compare NPCE & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- OXSQ
- Stock Information
- Founded
- NPCE 1997
- OXSQ 2003
- Country
- NPCE United States
- OXSQ United States
- Employees
- NPCE N/A
- OXSQ N/A
- Industry
- NPCE Medical Specialities
- OXSQ Blank Checks
- Sector
- NPCE Health Care
- OXSQ Finance
- Exchange
- NPCE Nasdaq
- OXSQ Nasdaq
- Market Cap
- NPCE 217.5M
- OXSQ 179.8M
- IPO Year
- NPCE 2021
- OXSQ N/A
- Fundamental
- Price
- NPCE $7.20
- OXSQ $2.92
- Analyst Decision
- NPCE Buy
- OXSQ
- Analyst Count
- NPCE 7
- OXSQ 0
- Target Price
- NPCE $16.00
- OXSQ N/A
- AVG Volume (30 Days)
- NPCE 76.8K
- OXSQ 398.9K
- Earning Date
- NPCE 08-13-2024
- OXSQ 08-13-2024
- Dividend Yield
- NPCE N/A
- OXSQ 14.38%
- EPS Growth
- NPCE N/A
- OXSQ N/A
- EPS
- NPCE N/A
- OXSQ 0.05
- Revenue
- NPCE $71,819,000.00
- OXSQ $47,492,283.00
- Revenue This Year
- NPCE $20.21
- OXSQ N/A
- Revenue Next Year
- NPCE $15.04
- OXSQ N/A
- P/E Ratio
- NPCE N/A
- OXSQ $59.86
- Revenue Growth
- NPCE 30.75
- OXSQ N/A
- 52 Week Low
- NPCE $5.75
- OXSQ $2.82
- 52 Week High
- NPCE $18.15
- OXSQ $3.29
- Technical
- Relative Strength Index (RSI)
- NPCE 46.93
- OXSQ 38.55
- Support Level
- NPCE $7.01
- OXSQ $2.92
- Resistance Level
- NPCE $8.34
- OXSQ $2.99
- Average True Range (ATR)
- NPCE 0.65
- OXSQ 0.02
- MACD
- NPCE -0.03
- OXSQ -0.00
- Stochastic Oscillator
- NPCE 31.52
- OXSQ 12.50
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.